Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Binod Dhakal

Showing results (41-50 of 178) with videos related to

Pageof 18
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|April 29, 2020
Monoclonal Gammopathies After Renal Transplantation: A Single-center StudyBhavna Bhasin, Aniko Szabo, Ruizhe Wu, et al.
Case Reports in Hematology|November 16, 2016
Reactivation of Pulmonary Tuberculosis following Treatment of Myelofibrosis with RuxolitinibMaheen Z Abidi, Javeria Haque, Parvathi Varma, et al.
Blood Reviews|August 19, 2020
Autonomic nervous system control of multiple myelomaYan Cheng, Fumou Sun, Anita D'Souza, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 12, 2018
Pharmacokinetics of High-Dose Propylene Glycol-Free Melphalan in Multiple Myeloma Patients Undergoing Autologous Hematopoietic Cell TransplantationBinod Dhakal, Anita D'Souza, Arjun Lakshman, et al.
Transplantation and Cellular Therapy|September 14, 2024
Racial and Ethnic Disparities in Autologous Hematopoietic Cell Transplantation Utilization in Multiple Myeloma Have Persisted Over Time Even After Referral to a Transplant CenterJames Fan Wu, Noel Estrada-Merly, Binod Dhakal, et al.
Contemporary Clinical Trials Communications|April 27, 2018
Rationale and design of DUAL study: Doxycycline to Upgrade response in light chain (AL) amyloidosis (DUAL): A phase 2 pilot study of a two-pronged approach of prolonged doxycycline with plasma cell-directed therapy in the treatment of AL amyloidosisAnita D'Souza, Kathryn Flynn, Saurabh Chhabra, et al.
The Lancet. Haematology|April 29, 2018
Disease burden, complication rates, and health-care costs of heparin-induced thrombocytopenia in the USA: a population-based studyBinod Dhakal, Lisa Baumann Kreuziger, Lisa Rein, et al.
Healthcare (Basel, Switzerland)|July 13, 2018
Developing a Case-Based Blended Learning Ecosystem to Optimize Precision Medicine: Reducing Overdiagnosis and OvertreatmentVivek Podder, Binod Dhakal, Gousia Ummae Salma Shaik, et al.
Eclinicalmedicine|June 13, 2020
Adjuvant doxycycline to enhance anti-amyloid effects: Results from the dual phase 2 trialAnita D'Souza, Aniko Szabo, Kathryn E Flynn, et al.
British Journal of Haematology|March 9, 2026
Changes in patient-reported distress and symptom burden during talquetamab therapy in multiple myelomaElizabeth Aughey, Noel Estrada-Merly, Othman Salim Akhtar, et al.
Pageof 18

Showing results (41-50 of 178) with videos related to

Sort By:
Pageof 18
Clinical Lymphoma, Myeloma & Leukemia|April 29, 2020
Monoclonal Gammopathies After Renal Transplantation: A Single-center StudyBhavna Bhasin, Aniko Szabo, Ruizhe Wu, et al.
Case Reports in Hematology|November 16, 2016
Reactivation of Pulmonary Tuberculosis following Treatment of Myelofibrosis with RuxolitinibMaheen Z Abidi, Javeria Haque, Parvathi Varma, et al.
Blood Reviews|August 19, 2020
Autonomic nervous system control of multiple myelomaYan Cheng, Fumou Sun, Anita D'Souza, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 12, 2018
Pharmacokinetics of High-Dose Propylene Glycol-Free Melphalan in Multiple Myeloma Patients Undergoing Autologous Hematopoietic Cell TransplantationBinod Dhakal, Anita D'Souza, Arjun Lakshman, et al.
Transplantation and Cellular Therapy|September 14, 2024
Racial and Ethnic Disparities in Autologous Hematopoietic Cell Transplantation Utilization in Multiple Myeloma Have Persisted Over Time Even After Referral to a Transplant CenterJames Fan Wu, Noel Estrada-Merly, Binod Dhakal, et al.
Contemporary Clinical Trials Communications|April 27, 2018
Rationale and design of DUAL study: Doxycycline to Upgrade response in light chain (AL) amyloidosis (DUAL): A phase 2 pilot study of a two-pronged approach of prolonged doxycycline with plasma cell-directed therapy in the treatment of AL amyloidosisAnita D'Souza, Kathryn Flynn, Saurabh Chhabra, et al.
The Lancet. Haematology|April 29, 2018
Disease burden, complication rates, and health-care costs of heparin-induced thrombocytopenia in the USA: a population-based studyBinod Dhakal, Lisa Baumann Kreuziger, Lisa Rein, et al.
Healthcare (Basel, Switzerland)|July 13, 2018
Developing a Case-Based Blended Learning Ecosystem to Optimize Precision Medicine: Reducing Overdiagnosis and OvertreatmentVivek Podder, Binod Dhakal, Gousia Ummae Salma Shaik, et al.
Eclinicalmedicine|June 13, 2020
Adjuvant doxycycline to enhance anti-amyloid effects: Results from the dual phase 2 trialAnita D'Souza, Aniko Szabo, Kathryn E Flynn, et al.
British Journal of Haematology|March 9, 2026
Changes in patient-reported distress and symptom burden during talquetamab therapy in multiple myelomaElizabeth Aughey, Noel Estrada-Merly, Othman Salim Akhtar, et al.
Pageof 18